THE TIGIT/CD226/CD155 AXIS AND THE EFFECTS OF COMBINING PD-1/PD-L1 BLOCKADE WITH TIGIT-TARGETING ANTIBODY THERAPY IN SYNGENEIC MURINE GLIOBLASTOMA MODELS

被引：1
|
作者：
Gokhale, Prafulla [1 ]
Iorgulescu, Bryan [1 ]
Klapholz, Max [2 ]
Poitras, Michael [1 ]
Eschle, Benjamin [1 ]
Freeman, Gordon [1 ]
Anderson, Ana [3 ]
Reardon, David [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
256
引用
收藏
页码：A277 / A278
页数：2
相关论文
共 50 条
  • [1] A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma
    Assal, Reem A.
    Elemam, Noha M.
    Mekky, Radwa Y.
    Attia, Abdelrahman A.
    Soliman, Aya Hesham
    Gomaa, Asmaa Ibrahim
    Efthimiadou, Eleni K.
    Braoudaki, Maria
    Fahmy, Sherif Ashraf
    Youness, Rana A.
    TRANSLATIONAL ONCOLOGY, 2024, 45
  • [2] DUAL TARGETING OF CD155/TIGIT AND PD-L1/PD-1 IMMUNE CHECKPOINTS POTENTIATES NATURAL KILLER CELL-MEDIATED CYTOTOXICITY IN MEDULLOBLASTOMA
    Monnikhof, Matthijs
    Schakelaar, Michael
    Meulenbroeks, Chris
    Quist, Matthias
    Perzolli, Alicia
    Selten, Aimee
    Koster, Celeste
    Maassen, Danielle
    Canelo, Alba Montoro
    Fredriks, Maureen
    Kaludjerovic, Vela
    Meeldijk, Jan
    Pijnappel, Emma
    Rebel, Heggert
    van Kempen, Sven
    Crnko, Sandra
    Frederico, Aniello
    Wesseling, Pieter
    Calkoen, Friso
    van der Lugt, Jasper
    ten Broeke, Toine
    Kool, Marcel
    Bovenschen, Niels
    NEURO-ONCOLOGY, 2024, 26
  • [3] Tigit, CD226 and PD-L1/PD-1 Are Highly Expressed By Marrow-Infiltrating T Cells in Patients with Multiple Myeloma
    Yadav, Mahesh
    Green, Cherie
    Ma, Connie
    Robert, Alberto
    Glibicky, Andrew
    Nakamura, Rin
    Sumiyoshi, Teiko
    Meng, Ray
    Chu, Yu-Waye
    Wu, Jenny
    Byon, John
    Woodard, Joseph
    Adamkewicz, Joanne
    Grogan, Jane
    Venstrom, Jeffrey M.
    BLOOD, 2016, 128 (22)
  • [4] Development of a bispecific antibody targeting PD-L1 and TIGIT with optimal cytotoxicity
    Zhong, Zhenwei
    Zhang, Mengyao
    Ning, Yanan
    Mao, Guanchao
    Li, Xiaopei
    Deng, Qi
    Chen, Xiaorui
    Zuo, Dongliang
    Zhao, Xiangyu
    Xie, Ermin
    Wang, Huajing
    Guo, Lina
    Li, Bohua
    Xiao, Kai
    He, Xiaowen
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Development of a bispecific antibody targeting PD-L1 and TIGIT with optimal cytotoxicity
    Zhenwei Zhong
    Mengyao Zhang
    Yanan Ning
    Guanchao Mao
    Xiaopei Li
    Qi Deng
    Xiaorui Chen
    Dongliang Zuo
    Xiangyu Zhao
    Ermin Xie
    Huajing Wang
    Lina Guo
    Bohua Li
    Kai Xiao
    Xiaowen He
    Scientific Reports, 12
  • [6] TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells
    Mao, Liang
    Xiao, Yao
    Yang, Qi-Chao
    Yang, Shao-Chen
    Yang, Lei-Lei
    Sun, Zhi-Jun
    ORAL ONCOLOGY, 2021, 121
  • [7] The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients
    Pawlowska, Anna
    Skiba, Wiktoria
    Suszczyk, Dorota
    Kurylo, Weronika
    Jakubowicz-Gil, Joanna
    Paduch, Roman
    Wertel, Iwona
    CANCERS, 2022, 14 (23)
  • [8] CD8+ T cells expressing both PD-1 and TIGIT but not CD226 are dysfunctional in acute myeloid leukemia (AML) patients
    Wang, Mengjie
    Bu, Jin
    Zhou, Maohua
    Sido, Jessica
    Lin, Yu
    Liu, Guanfang
    Lin, Qiwen
    Xu, Xiuzhang
    Leavenworth, Jianmei W.
    Shen, Erxia
    CLINICAL IMMUNOLOGY, 2018, 190 : 64 - 73
  • [9] Expression of CD155, PD-1 and PD-L1 in Non-Melanoma Skin Cancer: Implications for Treatment of Advanced Disease
    Farrow, N. E.
    Beasley, G. M.
    MacLeod, A. S.
    Sarah, M. A.
    Cognetta, A.
    Gromeier, M.
    Selim, M. A.
    Bigner, D. D.
    McLendon, R.
    Whitley, M. J.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S204 - S204
  • [10] Ex-vivo co-blockade of CD-155/TIGIT and PD-1/PD-L1 using CCAT-1, H19 and MALAT-1 LncRNAs in hepatocellular carcinoma
    Youness, R. A.
    Gomaa, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1433 - S1433
12345